Longevity Health Holdings, Inc. Increase (Decrease) in Accounts Payable
Longevity Health Holdings, Inc. (XAGE) reported Increase (Decrease) in Accounts Payable of $544.88 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-14
- Longevity Health Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$6.47K.
- Longevity Health Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $551.35K, a 73.91% increase year-over-year.
- Longevity Health Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $323.82K.
- Longevity Health Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$455.76K, a 483.39% decline year-over-year.
- Longevity Health Holdings, Inc. increase (decrease) in accounts payable for fiscal 2025 was $126.86K.
- Longevity Health Holdings, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$359.14K.
- Longevity Health Holdings, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$449.87K, a 142.44% decline from fiscal 2022.
- Longevity Health Holdings, Inc. increase (decrease) in accounts payable for fiscal 2022 was $1.06M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$6.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $544.88K 10-Q · filed 2026-08-14 | $868.71K derived: sum of 3 quarters · filed 2026-08-14 | $412.95K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $551.35K 10-Q · filed 2026-05-15 | $875.18K derived: sum of 2 quarters · filed 2026-05-15 | $419.42K derived: sum of 3 quarters · filed 2026-05-15 | $361.17K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $323.82K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$131.93K derived: sum of 2 quarters · filed 2026-03-31 | -$190.18K derived: sum of 3 quarters · filed 2026-08-14 | $126.86K 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$455.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$514.01K derived: sum of 2 quarters · filed 2026-08-14 | -$196.97K 10-Q · filed 2025-11-14 | -$353.17K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$58.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $258.79K 10-Q · filed 2026-08-14 | $102.59K derived: sum of 3 quarters · filed 2026-08-14 | $221.46K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $317.04K 10-Q · filed 2026-05-15 | $160.84K derived: sum of 2 quarters · filed 2026-05-15 | $279.71K derived: sum of 3 quarters · filed 2026-05-15 | $91.66K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$156.20K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$37.33K derived: sum of 2 quarters · filed 2026-03-31 | -$225.38K derived: sum of 3 quarters · filed 2026-03-31 | -$359.14K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $118.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$69.18K derived: sum of 2 quarters · filed 2025-11-14 | -$202.94K 10-Q · filed 2025-11-14 | -$1.25M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$188.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$321.82K 10-Q · filed 2025-08-14 | -$1.37M derived: sum of 3 quarters · filed 2025-08-14 | -$1.37M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$133.76K 10-Q · filed 2025-05-15 | -$1.18M derived: sum of 2 quarters · filed 2025-06-17 | -$1.18M derived: sum of 3 quarters · filed 2025-06-17 | -$742.73K derived: sum of 4 quarters · filed 2025-06-17 | |
| 2023-12-31 | -$1.04M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-06-17 | -$1.05M derived: sum of 2 quarters · filed 2025-06-17 | -$608.97K derived: sum of 3 quarters · filed 2025-06-17 | -$449.87K 10-K/A · filed 2025-06-17 | |
| 2023-09-30 | -$6.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $434.37K derived: sum of 2 quarters · filed 2024-11-14 | $593.46K 10-Q · filed 2024-11-14 | -$1.46M 10-Q · filed 2023-11-15 | $695.72K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $440.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $599.52K 10-Q · filed 2024-08-14 | $701.78K derived: sum of 3 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $159.10K 10-Q · filed 2024-05-15 | $261.36K derived: sum of 2 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $102.26K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.06M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $957.69K 10-Q · filed 2023-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |